Organogenesis Holdings (ORGO) Interest Coverage Ratio (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Interest Coverage Ratio of 181.29 for Q1 2026, up 8663.01% year-over-year from 2.07 in Q1 2025, and up 3432.52% quarter-over-quarter from 5.13 in Q4 2025.
Organogenesis Holdings (ORGO) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 181.29 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 8663.01% year-over-year to 181.29; the TTM figure through Mar 2026 stood at 0.13 (up 106.54% YoY), while the FY2025 annual figure was 2.24, up 2709.57% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 181.29, up from 5.13 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 181.29 in Q1 2026, with the low at 4.59 in Q2 2024.
- The 5-year median for Interest Coverage Ratio is 0.03 (2022), against an average of 10.55.
- The sharpest annual moves came in 2024 and 2026: Interest Coverage Ratio plunged 3025.23% in 2024, then surged 8663.01% in 2026.
- Organogenesis Holdings' Interest Coverage Ratio stood at 1.76 in 2022, then surged by 74.58% to 0.45 in 2023, then jumped by 271.04% to 0.77 in 2024, then surged by 570.8% to 5.13 in 2025, then soared by 3432.52% to 181.29 in 2026.
- Business Quant data shows ORGO's Interest Coverage Ratio at 181.29 in Q1 2026, 5.13 in Q4 2025, and 1.93 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 369.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 369.51 |
| Mar 31, 2026 | 181.29 |
| Dec 31, 2025 | 5.13 |
| Sep 30, 2025 | 1.93 |
| Jun 30, 2025 | -2.28 |
| Mar 31, 2025 | -2.12 |
| Dec 31, 2024 | 0.77 |
| Sep 30, 2024 | 1.89 |
| Jun 30, 2024 | -4.59 |
| Mar 31, 2024 | -0.51 |
| Dec 31, 2023 | -0.45 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -1.76 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | 14.05 |
| Sep 30, 2021 | 0.24 |